Marriage Counselors in Fernley, NV Accepting Medicare

4 Marriage Counselors found. Showing 1 - 4

Mrs. Laura Ahlstrom, LMFT-I Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 415 Hwy 95 South, Suite 702g, Fernley, NV 89408 Phone: 775-575-2284

Teelee Montgomery Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 415 Hwy 95a, Bldg. G, Suit 701, Fernley, NV 89408 Phone: 775-575-2144

Justine Enochs, MFT-I Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 415 Us Highway 95a S, Fernley, NV 89408 Phone: 775-575-2144

Ms. Jena D Blair, MFT-INTERN Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 415 Us Hwy 94 A South, Ste. G 701, Fernley, NV 89408 Phone: 775-575-2144    Fax: 775-575-2100

News Archive

FOLOTYN Phase 2 peripheral T-cell lymphoma study results published in Journal of Clinical Oncology

Allos Therapeutics, Inc. today announced that the Journal of Clinical Oncology has published data from the Company's pivotal Phase 2 PROPEL study demonstrating clinical activity of FOLOTYN® (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

World Bank President calls for new, more open approach to economic development

"World Bank President Robert Zoellick on Wednesday called on economists to rethink the way they look at issues affecting developing nations and said he was overhauling the way his institution approached research," Reuters reports (Wroughton, 9/29).

Elevated cholesterol is associated with breast cancer risk

A byproduct of cholesterol functions like the hormone estrogen to fuel the growth and spread of the most common types of breast cancers, researchers at the Duke Cancer Institute report.

Anti-CD73 molecule CPI-006 activates B cell responses to SARS-CoV-2

As the COVID-19 pandemic continues to cause an immense impact across many parts of the world, the role played by immune responses is becoming more evident every day. A recent funded paper published on the preprint server medRxiv* in September 2020 reports the initiation of a Phase I trial of a drug that increases antibody and cell-mediated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Read more Medical News

› Verified 2 days ago